Biogen Says Its Alzheimer’s Drug Shows Promise
(Cambridge, MA) — Biogen says its Alzheimer’s drug shows promise in slowing progress of the disease. It was produced in partnership with a Japanese company. Biogen says late-stage clinical trials show the drug reduced cognitive decline by 27-percent.
